First gene therapy for heart failure offered at NewYork-Presbyterian/Columbia
Wednesday, June 18, 2008 - 14:21
in Health & Medicine
NYC's only medical center offering promising therapy as part of CUPID clinical trial Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.
Read the whole article on Physorg
More from Physorg
Related
- First gene therapy for heart failure offered at NewYork-Presbyterian/ColumbiaWed, 18 Jun 2008, 15:21:40 EDT
- First trial of gene therapy for advanced heart failure shows promising resultsMon, 10 Nov 2008, 17:43:44 EST
- Gene therapy reversed heart damage in heart failureMon, 29 Dec 2008, 16:56:37 EST
- And the beat goes on: Scientists jump-start the heart by gene transferMon, 5 Oct 2009, 13:24:58 EDT
- Exercise is safe, improves quality of life in patients with chronic heart failureTue, 7 Apr 2009, 17:22:49 EDT